Dexmethylphenidate Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets, Capsules

Available Strengths: 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, 25 mg

Reference Brands: Focalin (USA), Focalin XR (USA)

Category: Neurology

Dexmethylphenidate is the active d-isomer of methylphenidate and is used to treat attention deficit hyperactivity disorder (ADHD). It helps increase attention and decrease impulsiveness and hyperactivity by affecting certain natural substances in the brain.

Product Description:

Dexmethylphenidate is the d-threo enantiomer of methylphenidate, the isomer that carries essentially all of the parent drug's activity at dopamine and noradrenaline transporters. Removing the inactive l-isomer means the same effect is achieved at roughly half the milligram dose of racemic methylphenidate. It is used for attention deficit hyperactivity disorder in children aged six and over, adolescents and adults.

The immediate-release tablet lasts about four to six hours. The extended-release capsule uses a bimodal bead system — half immediate, half delayed — so one morning dose covers the school or working day. Adverse effects are the stimulant class set: reduced appetite, insomnia, raised heart rate and blood pressure, and growth monitoring in children. The boxed warning covers abuse, misuse and addiction.

Sourcing notes. Methylphenidate is Schedule II under the 1971 UN Convention, and dexmethylphenidate is Schedule II in the US and controlled alongside it in most markets, so trade needs import and export authorisations and falls under national quota. Registration is largely a US product; many markets register only racemic methylphenidate, so buyers elsewhere should confirm whether they need the enantiomer at all. Generic immediate-release tablets and extended-release capsules exist, but the capsule's release profile makes bioequivalence demanding. Diversion controls apply at every stage of storage and transport.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.